SynthesisThe Cochrane database of systematic reviews2010
Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies.
Synthesis in The Cochrane database of systematic reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Peripartum cardiomyopathy: a review of prevalence and treatment trends from an African perspective.Frontiers in cardiovascular medicine · 2025Review
- Peripartum cardiomyopathy: a comprehensive and contemporary review.Heart failure reviews · 2024Review
- Pharmacological interventions for peripartum cardiomyopathy.The Cochrane database of systematic reviews · 2024Article
- A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy.Cureus · 2021Review
- Cabergoline in the Treatment of Peripartum Cardiomyopathy.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2016Article
- Prospective study on changes in blood variables in pregnant women at higher risk of peripartum cardiomyopathy.ESC heart failure · 2015Article
- Gestational Weight Gain and Peripartum Cardiomyopathy in a Twin Pregnancy.Case reports in obstetrics and gynecology · 2015Article
- Peripartum cardiomyopathy in a woman with preeclampsia with twin pregnancy.BMJ case reports · 2014Article
- Peripartum cardiomyopathy.Annals of medical and health sciences research · 2013Review
- [Peripartum cardiomyopathy: diagnostic and therapeutic challenge].Der Anaesthesist · 2013Article
- Labor complicated by mitral stenosis.Proceedings (Baylor University. Medical Center) · 2013Article
- Pregnancy in a patient with cancer and heart failure: challenges and complexities.Journal of the advanced practitioner in oncology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPeripartum cardiomyopathy (PPCM or PCMO) is a rare disease of unknown etiology, characterised by an acute onset of heart failure in women in the late stage of pregnancy or in the early months postpartum.
objectivesTo assess the effectiveness and safety of any intervention for the care of women and/or their babies with a diagnosis of peripartum cardiomyopathy. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (27 July 2010) and the reference lists of identified studies. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials of any intervention for treating peripartum cardiomyopathy. Such interventions include: drugs; cardiac monitoring and treatment; haemodynamic monitoring and treatments; supportive therapies and heart transplant. DATA COLLECTION AND ANALYSIS: Two authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction. Data entry was checked. MAIN
resultsWe identified and included one pilot study, involving 20 women, undertaken in South Africa. Women were diagnosed postnatally and included in the study within 24 hours of diagnosis. AUTHORS'
conclusionsThere are insufficient data to draw any firm conclusions. Treatment with bromocriptine appears promising, although women would be unable to breastfeed due to suppression of lactation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.